Related Experiment Videos
Repeat laparotomy in ovarian carcinoma after primary surgery
J C Archer1, R P Soeters, B Bloch
1Department of Obstetrics and Gynaecology, University of Cape Town.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|September 21, 1991
Summary
Repeat laparotomy in advanced ovarian cancer improves staging accuracy and cytoreductive surgery success. This study found a 58% success rate for reducing residual disease to less than 2 cm.
Area of Science:
- Gynecologic Oncology
- Surgical Oncology
- Ovarian Cancer Research
Background:
- Malignant ovarian disease often requires multidisciplinary management.
- Accurate staging and cytoreductive surgery are critical for improving patient outcomes.
- Referral to specialized centers can optimize treatment strategies.
Purpose of the Study:
- To evaluate the role of re-laparotomy in accurate staging of malignant ovarian disease.
- To assess the efficacy of cytoreductive surgery in patients referred after primary surgery.
- To determine the impact of re-laparotomy on disease staging and residual tumor burden.
Main Methods:
- Retrospective review of 32 patients with malignant ovarian disease.
- All patients underwent re-laparotomy for staging and cytoreductive surgery.
- Analysis of initial staging, post-re-laparotomy staging, and residual disease after surgery.
Main Results:
- 75% of patients presented with Stage I or II disease; 25% with Stage III/IV.
- Re-laparotomy upstaged 20.8% of patients initially diagnosed with Stage I/II disease.
- The overall success rate for cytoreductive surgery (residual disease < 2 cm) was 58%.
Conclusions:
- Re-laparotomy is valuable for accurate staging in ovarian cancer patients post-primary surgery.
- Cytoreductive surgery following re-laparotomy achieves significant tumor reduction in a majority of cases.
- Specialized gynecological oncology units play a crucial role in managing advanced ovarian malignancies.